Mon, Dec 22, 2014
A A A
Welcome Guest
Free Trial RSS
Get FREE trial access to our award winning publications
Alternative Market Briefing

Multifonds’ survey finds fund administrators believe AIFMD will be a catalyst for convergence

Monday, September 10, 2012

Beverly Chandler, Opalesque London: Multifonds’ latest survey of the fund administration industry shows that more than two thirds, some 69%, of industry respondents, with combined assets under administration of $16 trillion, believe AIFMD will accelerate the convergence of long only funds and hedge funds.

The firm says that although the Directive’s implementation deadline of 22 July 2013 is looming, many of those surveyed felt that they were not on target to be ready for AIFMD implementation. The research found that a fifth of respondents (20%) felt they were behind schedule and would not be ready within the next 12 months.

Multifonds’ survey, which received more than 50 responses from senior participants across the global fund administration industry, also asked which elements of AIFMD will have the most significant impact on respondents. Here, some 57% of fund administrators believed that depositary liability was the most challenging element, followed by operational requirements and risk and liquidity management, both standing at 45%.

With funds having to conform to all the Directive’s rules to market to European investors when AIFMD comes into effect, AIFMD represents a significant opportunity for Europe, Multifonds believes. 63% of those surveyed agreed that AIFMD will make Europe a more attractive jurisdiction for a......................

To view our full article Click here

Today's Exclusives Today's Other Voices More Exclusives
Previous Opalesque Exclusives                                  
More Other Voices
Previous Other Voices                                               
Access Alternative Market Briefing


  • Top Forwarded
  • Top Tracked
  • Top Searched
  1. Investing - Big hedge funds win again on PetSmart, Riverbed, RBS sells real estate loans to hedge fund Cerberus, Talisman energy speculation: Which hedge funds could benefit?[more]

    Big hedge funds win again on PetSmart, Riverbed From CNBC.com: Another week, another set of wins for activist investors. On Sunday, pet supply retailer PetSmart agreed to the largest leveraged buyout of the year at $8.7 billion. Hedge fund firm JANA Partners had been pushing for a sale a

  2. Outlook - Hedge fund manager who remembers 1998 rout says prepare for pain, Bond guru Bill Gross predicts U.S. economic growth to dip to 2%[more]

    Hedge fund manager who remembers 1998 rout says prepare for pain From Bloomberg.com: Stephen Jen landed in Hong Kong in early January 1997 as Morgan Stanley’s newly minted exchange-rate strategist for Asia. He was soon working around the clock when investors began targeting the region’s

  3. Investing - Hedge funds get boost from healthcare in 2014, Paulson & Co takes stake in Salix on heels of inventory issues[more]

    Hedge funds get boost from healthcare in 2014 From Valuewalk.com: The healthcare sector started the year on a turbulent note, as stocks of many major biotechnology companies were battered. However, most of the players in this sector have bounced back. The BarclayHedge Healthcare & Biotec

  4. North America - Why Steve Cohen, Connecticut hedge fund billionaire, gives so much in New York[more]

    From Insidephilantrophy.com: Billionaire Steve Cohen was born in Great Neck, New York before attending Wharton, working on Wall Street and then founding SAC Capital Advisors in Connecticut. Though his company (Point72) and foundation are based in Connecticut, Cohen and Alexandra are deeply connected

  5. Investing - Soros buys a highly speculative biotech in the third quarter[more]

    From Fool.com: …The Soros Fund bought 25,000 shares of the struggling small-cap biopharma Aegerion Pharmaceuticals in the third quarter. For those of you who haven't heard of this name, suffice to say that this was a surprising buy in light of the company's recent problems and poor outlook going for